Biocentis

About:

Spin-out of Imperial College London developing ground-breaking vector and pest control solutions for a healthier and more sustainable world

Website: https://biocentis.com/

Top Investors: Neurone

Description:

We are a biotech company re-shaping the future of insect control with a unique technology platform that combines environmental sustainability and unprecedented effectiveness. As a spin-out from Imperial College London, a global leader in genetic pest control, we build upon over 20 years of research by our scientific founders, whose pioneering work in genetic control technologies has garnered global recognition. With a presence in the UK and Italy, we leverage the experience of a diverse and accomplished team from 7 countries with unparalleled experience in the scientific and technological fields and an outstanding track record in company building and management.

Total Funding Amount:

3M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2022-01-13

Contact Email:

info(AT)biocentis.com

Founders:

Andrew Hammond, Federico Guelpa, Federico Guelpa, Giorgio Rocca, Kyros Kyrou, Teodoro D'Ambrosio

Number of Employees:

11-50

Last Funding Date:

2022-02-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai